jrnl6105

Publication Venue For

  • Role of iBALT in Respiratory Immunity. 2020
  • Cancer Explant Models. 2019
  • Molecular Virology of Chikungunya Virus. 2019
  • FCRLA—A resident endoplasmic reticulum protein that associates with multiple immunoglobulin isotypes in B lineage cells.  408:47-65. 2017
  • Emerging roles for the FCRL family members in lymphocyte biology and disease.  382:29-50. 2014
  • Human FcR polymorphism and disease.  382:275-302. 2014
  • Molecular determinants of influenza virus pathogenesis in mice.  385:243-274. 2014
  • The molecular basis of IL-10 function: From receptor structure to the onset of signaling.  380:191-212. 2014
  • The old but new IgM Fc receptor (Fc;R).  382:3-28. 2014
  • Encoding stability versus flexibility: Lessons learned from examining epigenetics in T helper cell differentiation.  356:145-164. 2012
  • A role for RNAi in heterochromatin formation in Drosophila.  320:185-209. 2008
  • Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease..  325:417-470. 2008
  • The foamy virus envelope glycoproteins.  277:111-129. 2003
  • Fc receptor homologs (FcRH1-5) extend the Fc receptor family.  266:85-112. 2002
  • Role of mucosal antibodies in viral infections.  260:201-228. 2001
  • Selection in the mature B cell repertoire.  252:97-105. 2000
  • Recombination-activating genes, transposition, and the lymphoid-specific combinatorial immune system: A common evolutionary connection.  248:111-135. 2000
  • Signal transduction and the coordination of B lymphocyte development and function I. Transduction of BCR signals from the cell membrane to the nucleus. Introduction.  245:V-X. 2000
  • Signal transduction via the B-cell antigen receptor: The role of protein tyrosine kinases and protein tyrosine phosphatases.  245 I:1-51. 1999
  • Paired immunoglobulin-like receptors of activating and inhibitory types.  244:137-149. 1999
  • CD21(high) IgM(High) splenic B cells enriched in the marginal zone: Distinct phenotypes and functions.  246:45-52. 1999
  • Recombinant viruses as vectors for mucosal immunity.  236:255-273. 1999
  • Diphtheria toxin fusion proteins.  234:63-81. 1998
  • Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells.  218:93-117. 1996
  • Viral protein X.  193:121-132. 1995
  • CD5 transgenic mice.  194:209-217. 1994
  • Early B-cell repertoires.  182:81-84. 1992
  • Ligand specificity and repertoire development of murine TCRγδ cells.  173:133-139. 1991
  • Factor H..  153:147-162. 1990
  • Biodegradable microspheres: vaccine delivery system for oral immunization..  146:59-66. 1989
  • Immune responses to influenza virus in orally and systemically immunized mice..  146:91-99. 1989
  • Liposomes as oral adjuvants..  146:51-58. 1989
  • Oral immunization: past and present..  146:3-11. 1989
  • Pauciclonal B cell involvement in production of immunoglobulin in scid Ig+ mice..  152:137-147. 1989
  • Reconstitution of lymphocyte subsets in scid mice by transplantation of fetal primordia..  152:161-168. 1989
  • Systemic immunization for the induction of IgA responses..  146:161-168. 1989
  • Expression of the murine proto-oncogene bcl-2 is stage specific and cell-type specific..  141:332-336. 1988
  • Immunoglobulin gene rearrangements in pre-B cells..  135:125-138. 1987
  • Epstein-Barr virus induced differentiation of early B-lineage cells..  132:246-250. 1986
  • Genetic approaches to the study of disease resistance: with special emphasis on the use of recombinant inbred mice..  124:21-35. 1986
  • Genetic control of the susceptibility to pneumococcal infection..  124:103-120. 1986
  • Purification and biochemical analysis of antigen-specific suppressor factors isolated from T-cell hybridomas..  100:53-59. 1982